Long-Term Neurological Safety in B-Cell Lymphoma Patients Treated With Anti-CD19 CAR T-Cell Therapy.

Ursu R, Maillet D, Belin C, Moroni C, Cuzzubbo S, Vernier V, Sirven-Villaros L, Carreau C, Di Blasi R, Thieblemont C, Carpentier AF.